Tel:: +49 (0)241 95 163 153
Fax:: +49 (0)241 95 163 155
E-Mail:: orders@anticorps-enligne.fr

Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Peptide

ALOX5AP Reactivité: Humain Hôte: Lapin BP

N° du produit ABIN2763850

Aperçu rapide pour Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Peptide (ABIN2763850)

Antigène

ALOX5AP (Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP))

Origine

Humain

Source

Lapin

Application

Blocking Peptide (BP)

Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) (C-Term) peptide
ALOX5AP Reactivité: Humain Hôte: Synthetic BP, Imm

Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) (Internal Region) peptide
ALOX5AP Reactivité: Humain, Chien Hôte: Synthetic BP, Imm

Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) (Intermediate Domain) peptide
ALOX5AP Reactivité: Humain Hôte: Synthetic BP, BI

Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) (C-Term) peptide
ALOX5AP Reactivité: Humain Hôte: Synthetic BP, BI

Restrictions

For Research Use only
Stock

-80 °C
Antigène

ALOX5AP (Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP))

Sujet

Seems to be required for the activation of 5-LO (5-lipoxygenase). Could play an essential role in the transfer of arachidonic acid to 5-LO. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes. Genetic variations in FLAP may be a cause of susceptibility to ischemic stroke [MIM:601367], also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.

Vous êtes ici: